The role of human microbiota in breast cancer pathogenesis and treatment

This publication has 20 references indexed in Scilit:

• Microbial modulation as a game changer: Boosting immunotherapy efficacy in breast cancer
  Seminars in Cancer Biology, 2025
• The combination of flaxseed lignans and PD-1/ PD-L1 inhibitor inhibits breast cancer growth via modulating gut microbiome and host immunity
  Drug Resistance Updates, 2025
• Urolithin A inhibits breast cancer progression via activating TFEB-mediated mitophagy in tumor macrophages
  Journal of Advanced Research, 2024
• Gut microbiome in association with chemotherapy‐induced toxicities among patients with breast cancer
  Cancer, 2024
• Targeting systemic and gut microbial metabolism in ER+ breast cancer
  Trends in Endocrinology & Metabolism, 2024
• The gut microbiota in breast cancer development and treatment: The good, the bad, and the useful!
  Gut Microbes, 2023
• The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer
  Cell Metabolism, 2022
• The involvement of oncobiosis and bacterial metabolite signaling in metastasis formation in breast cancer
  Cancer and Metastasis Reviews, 2021
• Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8+ T cell immunity
  Cell Metabolism, 2021
• Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression
  Nature Communications, 2020